These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38626593)

  • 1. Apixaban for the treatment of acute splanchnic vein thrombosis: A pilot study.
    Kim SA; Choi GH; Lee JY; Jang ES; Lee JO; Kim JW; Jeong SH; Bang SM
    Thromb Res; 2024 May; 237():181-183. PubMed ID: 38626593
    [No Abstract]   [Full Text] [Related]  

  • 2. Apixaban and rivaroxaban in patients with cerebral venous thrombosis.
    Covut F; Kewan T; Perez O; Flores M; Haddad A; Daw H
    Thromb Res; 2019 Jan; 173():77-78. PubMed ID: 30481600
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis.
    Serrao A; Merli M; Lucani B; Aprile F; Fiori L; Gioia S; Breccia M; Riggio O; Chistolini A
    Eur J Clin Invest; 2021 Jan; 51(1):e13356. PubMed ID: 33180323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apixaban in the treatment of venous thrombosis associated with permanent pacemaker implantation].
    Carrizo S; Figueroa JA; Vivero A
    Medicina (B Aires); 2015; 75(6):410-2. PubMed ID: 26707667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty.
    Mochizuki T; Ikari K; Yano K; Hiroshima R; Ishibashi M; Okazaki K
    Mod Rheumatol; 2019 Jul; 29(4):682-686. PubMed ID: 30041559
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
    Arachchillage DR; Besser M; Maclean R; Baglin T; van Veen JJ
    Thromb Res; 2016 Jul; 143():137-40. PubMed ID: 27244105
    [No Abstract]   [Full Text] [Related]  

  • 7. Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial.
    Liu X; Johnson M; Mardekian J; Phatak H; Thompson J; Cohen AT
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26627879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
    Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
    Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual case of venous thrombosis.
    Jones O; Gooding R
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28314810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of characteristics and dosing regimens in patients with new or recurrent thrombosis on apixaban and rivaroxaban.
    Dreucean D; Nguyen SN; Donahue KR; Salazar E; Ruegger MC
    J Thromb Thrombolysis; 2021 Jul; 52(1):161-169. PubMed ID: 33099722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apixaban-induced subdural bleeding: case presentation and literature review.
    Alayad E; Khairy S; Aloraidi A
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29602894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pylephlebitis treated with apixaban.
    Hale GR; Sakkal LA; Galanis T
    Hosp Pract (1995); 2019 Oct; 47(4):192-195. PubMed ID: 31545676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents.
    Cornell RF; Goldhaber SZ; Engelhardt BG; Moslehi J; Jagasia M; Harrell S; Rubinstein SM; Hall R; Wyatt H; Piazza G
    Br J Haematol; 2020 Aug; 190(4):555-561. PubMed ID: 32314352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apixaban (Eliquis) in deep vein thrombosis and pulmonary embolism. Warfarin remains the standard therapy.
    Prescrire Int; 2015 Sep; 24(163):206. PubMed ID: 26417627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
    Goldhaber SZ; Ageno W; Casella IB; Chee KH; Schellong S; Singer DE; Desch M; Reilly PA; Donado E; Tang W; Voccia I; Schulman S
    Am J Med; 2020 Aug; 133(8):936-945. PubMed ID: 32325043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study.
    ; Buller H; Deitchman D; Prins M; Segers A
    J Thromb Haemost; 2008 Aug; 6(8):1313-8. PubMed ID: 18541000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
    Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R
    PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve.
    Jawitz OK; Wang TY; Lopes RD; Chavez A; Boyer B; Kim H; Anstrom KJ; Becker RC; Blackstone E; Ruel M; Thourani VH; Puskas JD; Gerdisch MW; Johnston D; Capps S; Alexander JH; Svensson LG
    Am Heart J; 2020 Sep; 227():91-99. PubMed ID: 32693197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive evaluation of apixaban in the treatment of venous thromboembolism.
    Koehl JL; Hayes BD; Al-Samkari H; Rosovsky R
    Expert Rev Hematol; 2020 Feb; 13(2):155-173. PubMed ID: 31958251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.